A programmable encapsulation technology is developed to reduce bacterial immunogenicity and proliferation after systemic administration. The cross‐linked polymer networks around individual bacteria enable immunogenic shielding and permit selective proliferation in tumors, allowing the bacteria to convert tumor‐accumulated ammonia into L‐arginine and ...
Jianhui Yang +12 more
wiley +1 more source
Causes and outcomes of pediatric thrombotic microangiopathy. [PDF]
Scully M.
europepmc +1 more source
Allele burden expansion in <i>JAK2</i> <sup>V617F</sup> and <i>CALR</i>-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment. [PDF]
Ng ZY +18 more
europepmc +1 more source
Concurrent Howell-Jolly body-like inclusions, Barr bodies and Döhle bodies in an immunosuppressed patient with sepsis. [PDF]
Panakkal V, Matsumoto NP.
europepmc +1 more source
Further insights into the application of the TFR prognostic score (TPS) in CML patients attempting TFR. [PDF]
Claudiani S, Metelli S, Milojkovic D.
europepmc +1 more source
Crystalline masquerade: Pseudo-Auer rods in multiple myeloma. [PDF]
Peng C, Sun M, Chen H.
europepmc +1 more source
Correction: Dysfibrinogenemia in Pregnancy: A Case Series Highlighting Diagnostic Challenges and Multidisciplinary Management. [PDF]
Mahurkar S +3 more
europepmc +1 more source
Correction to "Transcranial Doppler Ultrasound Velocity Measurements in Children With Sickle Cell Disease in Kenya". [PDF]
europepmc +1 more source

